Description

Nabota 100 units: Benchmark Quality, Safety, and FDA Approval

Nabota 100 units is a premium botulinum toxin type A developed by the South Korean pharmaceutical giant Daewoong Pharmaceutical. It is one of the very few Korean neurotoxins to receive official FDA (USA) and EMA (Europe) approvals, validating its exceptional safety, purity, and global efficacy. Manufactured using the proprietary HI-PURE technology, the product is stripped of unnecessary impurities, minimizing the foreign protein load on the body. This significantly reduces the risk of antibody formation and guarantees a rapid, stable, and highly predictable clinical outcome.

Key Benefits Nabota 100 units:

Global Recognition (FDA & EMA): Strict international certifications ensure the highest level of clinical safety and patient trust.

HI-PURE Technology: Ultra-high purification prevents the development of resistance, even with years of repeated treatments.

Rapid Onset: Initial signs of muscle relaxation appear very quickly, often by the second day post-injection.

Precision Targeting: The product exhibits minimal diffusion, allowing the practitioner to meticulously treat complex dynamic wrinkles without affecting adjacent muscles.

Indications:

Correction of moderate to severe dynamic wrinkles in the upper third of the face (forehead, glabella, crow’s feet).

Treatment of masseter muscle hypertrophy (bruxism, V-line facial contouring).

Correction of platysmal bands (neck rejuvenation).

Treatment of localized hyperhidrosis.

Specifications:

Active Ingredient: Botulinum Toxin Type A (100 Units).

Form: Lyophilized powder (1 vial).

Manufacturer: Daewoong Pharmaceutical (South Korea).